Gilead offers Egypt new hepatitis C drug at 99 percent discount Reuters India The World Health Organization estimates that more than 150 million people worldwide are chronically infected, most of them in developing countries, putting them at risk of cirrhosis and liver cancer. Other companies such as Johnson & Johnson, AbbVie, ... |